858 related articles for article (PubMed ID: 30967140)
1. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
2. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
Thomas DL
Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356
[TBL] [Abstract][Full Text] [Related]
3. [Update on the 2016 WHO classification of tumors of the central nervous system - Part 1: Diffusely infiltrating gliomas].
Švajdler M; Rychlý B; Zámečník J; Švajdler P
Cesk Patol; 2017; 53(1):12-21. PubMed ID: 28248117
[TBL] [Abstract][Full Text] [Related]
4. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of tumors of the central nervous system.
Kristensen BW; Priesterbach-Ackley LP; Petersen JK; Wesseling P
Ann Oncol; 2019 Aug; 30(8):1265-1278. PubMed ID: 31124566
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology and clinical implications of diffuse glioma.
Chai R; Fang S; Pang B; Liu Y; Wang Y; Zhang W; Jiang T
Chin Med J (Engl); 2022 Dec; 135(24):2914-2925. PubMed ID: 36728558
[TBL] [Abstract][Full Text] [Related]
7. [Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors. German version].
Malzkorn B; Reifenberger G
Pathologe; 2019 Mar; 40(2):131-139. PubMed ID: 30790013
[TBL] [Abstract][Full Text] [Related]
8. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016.
Malzkorn B; Reifenberger G
Curr Opin Oncol; 2016 Nov; 28(6):494-501. PubMed ID: 27606698
[TBL] [Abstract][Full Text] [Related]
9. Genomic Molecular Classification of CNS Malignancies.
Spino M; Snuderl M
Adv Anat Pathol; 2020 Jan; 27(1):44-50. PubMed ID: 31714292
[TBL] [Abstract][Full Text] [Related]
10. Advances in Diagnostic Immunohistochemistry for Primary Tumors of the Central Nervous System.
Meredith DM
Adv Anat Pathol; 2020 May; 27(3):206-219. PubMed ID: 30720470
[TBL] [Abstract][Full Text] [Related]
11. Update on Circumscribed Gliomas and Glioneuronal Tumors.
Chen J; Dahiya SM
Surg Pathol Clin; 2020 Jun; 13(2):249-266. PubMed ID: 32389265
[TBL] [Abstract][Full Text] [Related]
12. Embryonal tumors in the WHO CNS5 classification: A Review.
Gianno F; Miele E; Antonelli M; Giangaspero F
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathology of paediatric central nervous system tumours.
Chiang JC; Ellison DW
J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
[TBL] [Abstract][Full Text] [Related]
14. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic molecular markers in common adult gliomas.
Rivera AL; Pelloski CE
Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
[TBL] [Abstract][Full Text] [Related]
16. [Guidelines for adult diffuse gliomas WHO grade II, III and IV: pathology and biology. Société franc¸aise de neuropathologie . Réseau de neuro-oncologie pathologique].
Figarella-Branger D; Labrousse F; Mohktari K; ;
Ann Pathol; 2012 Oct; 32(5):318-27. PubMed ID: 23141938
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of malignant gliomas.
Belda-Iniesta C; de Castro Carpeño J; Casado Sáenz E; Cejas Guerrero P; Perona R; González Barón M
Clin Transl Oncol; 2006 Sep; 8(9):635-41. PubMed ID: 17005465
[TBL] [Abstract][Full Text] [Related]
18. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
[TBL] [Abstract][Full Text] [Related]
19. Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update.
Whitfield BT; Huse JT
Brain Pathol; 2022 Jul; 32(4):e13062. PubMed ID: 35289001
[TBL] [Abstract][Full Text] [Related]
20. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Fuller CE; Jones DTW; Kieran MW
Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
